TSH receptor autoantibodies – a personal experience
Open Access
- 9 July 2026
- journal article
- review article
- Published by Springer Nature in Thyroid Research
- Vol. 19 (1) , 21
Abstract
Nineteen fifty six was a pivotal year in our understanding of thyroid disease with the discovery of long acting thyroid stimulator (LATS) in the serum of pKeywords
This publication has 47 references indexed in Scilit:
- Targeted protein degradation: current molecular targets, localization, and strategiesDrug Discovery Today, 2024
- TSHR-based chimeric antigen receptor T cell specifically deplete auto-reactive B lymphocytes for treatment of autoimmune thyroid diseaseInternational Immunopharmacology, 2023
- The First Orally Active Low Molecular Weight Agonists for the LH Receptor: Thienopyr(im)idines with Therapeutic Potential for Ovulation InductionChemBioChem, 2002
- Cloning, sequencing and expression of human TSH receptorBiochemical and Biophysical Research Communications, 1990
- Molecular cloning, sequence and functional expression of the cDNA for the human thyrotropin receptorBiochemical and Biophysical Research Communications, 1989
- Auto-Immunity and Auto-Immune Disease1972
- Characterisation of long-acting thyroid stimulator γG binding proteinBiochimica et Biophysica Acta (BBA) - Protein Structure, 1971
- The nature of the interaction between thyroid stimulating γG-globulin (long-acting thyroid stimulatory) and thyroid tissueBiochimica et Biophysica Acta (BBA) - General Subjects, 1970
- The thyroid-stimulating properties of long-acting thyroid stimulator γG-globulin subunitsBiochimica et Biophysica Acta (BBA) - General Subjects, 1969
- The long‐acting thyroid stimulatorClinical Pharmacology & Therapeutics, 1966